Radiotherapy-induced mucositis is breast-conserving cancer patients. Acute radiodermatitis, Localized skin eruption due to drugs and medicament
Conditions
Interventions
Intervention 1: Control group: Patients undergo radiotherapy, will receive placebo hydrogel containing glycerin and green dye made by Mashhad University of Medical Sciences. Patients will use this hyd
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Female patients diagnosed with breast tissue cancer Age over 18 years No concomitant chemotherapy No previous radiotherapy to the chest area Minimum radiation of 50 Gy during treatment BMI 20-30 Breast conserving surgery
Exclusion criteria
Exclusion criteria: Existence of underlying diseases hypersensitivity to Portulaca oleracea Patients with metastatic carcinoma to the breast Inability of the patient to implement the treatment protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of dermatitis. Timepoint: At the beginning of the study and every week for 6 weeks. Method of measurement: Physician evaluation checklist of incidence and severity of disease for the radiotherapy oncology group (RTOG).;Severity of dermatitis. Timepoint: At the beginning of the study and every week for 6 weeks. Method of measurement: Physician evaluation checklist of incidence and severity of disease for the radiotherapy oncology group (RTOG). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: at the beginning and the end of the study. Method of measurement: Ware & Sherbourne's quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Reza Askari
Mashhad University of Medical Sciences
Outcome results
None listed